Physician profile
Theron C Smith
NPI 1477516987
$2,071.01
in general payments reported to CMS, 2019-2025
16 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $90.69 · 2021: $230 · 2023: $460 · 2024: $607 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,185.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $383.64 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $370.76 | 2019-2024 | |
| Biotissue Holdings INC. | $129.00 | 2023 | |
| Alcon Vision LLC | $125.00 | 2023 | Rhopressa, Simbrinza, Rocklatan |
| Apellis Pharmaceuticals, INC. | $121.84 | 2024 | Syfovre |
| Dompe US, INC. | $121.60 | 2024 | Oxervate |
| Horizon Therapeutics Plc | $120.00 | 2023 | Tepezza |
| Amgen INC. | $118.52 | 2025 | Tepezza |
| Coopervision INC. | $115.47 | 2019-2023 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $107.50 | 2021 | |
| Oyster Point Pharma, INC. | $105.57 | 2024 | Tyrvaya |
| Optos, INC. | $100.18 | 2019 | |
| Shire North American Group INC | $97.72 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Allergan, INC. | $17.57 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theron Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.